Cargando…
Predictability of Nonremitting Depression After First 2 Weeks of Antidepressant Treatment: A VAST‐D Trial Report
OBJECTIVE: In this secondary analysis of data from the Veterans Affairs Augmentation and Switching Treatments for Improving Depression Outcomes (VAST‐D) study, the authors sought to determine the effectiveness of early improvement (or lack thereof) for predicting remission from depression with antid...
Autores principales: | Hicks, Paul B., Sevilimedu, Varadan, Johnson, Gary R., Tal, Ilanit, Chen, Peijun, Davis, Lori L., Vertrees, Julia E., Mohamed, Somaia, Zisook, Sidney |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Psychiatric Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176018/ https://www.ncbi.nlm.nih.gov/pubmed/36101874 http://dx.doi.org/10.1176/appi.prcp.20190003 |
Ejemplares similares
-
Adding antidepressants to antipsychotics for treatment of subsyndromal depressive symptoms in schizophrenia: Impact on positive and negative symptoms
por: Vahia, Ipsit V., et al.
Publicado: (2013) -
Sex Differences in Peritraumatic Inflammatory Cytokines and Steroid
Hormones Contribute to Prospective Risk for Nonremitting Posttraumatic Stress
Disorder
por: Lalonde, Chloe S., et al.
Publicado: (2021) -
Suicide bereavement and complicated grief
por: Tal Young, Ilanit, et al.
Publicado: (2012) -
Vermin Vastness
Publicado: (1884) -
How do serotonergic psychedelics treat depression: The potential role of neuroplasticity
por: Artin, Hewa, et al.
Publicado: (2021)